| Product No | EMEA/H/C/006058 |
|---|---|
| Brand Name | Bimervax |
| Nonproprietary Name | COVID-19 Vaccine (recombinant, adjuvanted) |
| API | SARS-CoV-2 virus recombinant spike (S) protein receptor binding domain (RBD) fusion heterodimer – B.1.351-B.1.1.7 strains |
| ATC Code | J07BN |
| Indications | Bimervax is indicated as a booster for active immunisation to prevent COVID-19 in individuals 16 years of age and older who have previously received a mRNA COVID-19 vaccine |
| Orphan Drug | no |
| Generics | no |
| Marketing Authorization Holder | Hipra Human Health S.L. |
| Status | Authorised(授权) |
| Authorization Date | 2023-03-30 |
| Version | 0 |
| Condition Approval | no |
| Exceptions | no |
| Biosimilar | no |
| Details | 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息) |
Extended Information